Eli Lilly Booked a New High

Published on Monday, 02 July 2012 12:34 Written by TradersHuddle Wire

New York, July 2nd (TradersHuddle.com) - Shares of Eli Lilly & Co. (NYSE:LLY) booked a new 52 week high today by trading above $42.91, traders are definitely monitoring Eli Lilly's price action to see if this move attracts further buying into the stock.

Eli Lilly (NYSE:LLY) principal activities are to develop, manufacture and market pharmaceutical-based health care solutions. The company specializes in research and development, production and marketing of products for the treatment of diabetes worldwide, such as insulin and insulin delivery devices.. Some of the company's patents include Zyprexa, Prozac, Permax, Humulin, Evista, Humalog, Humatrope, Vancocin, Keflex, Nebcin , Lorabid, Gemzar, Tylan, and Rumensin.

Eli Lilly is currently trading 0.21% versus its previous trading session close, and it has calculated support and resistance at $39.25 and $42.47 respectively. Clearly, with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range.

The overall market index S&P 500 is trading lower by -0.24% from its previous trading close, which means that Eli Lilly stock is outperforming the overall market.